RWM
BPMC

Raffa Wealth Management’s Blueprint Medicines BPMC Stock Holding History

Raffa Wealth Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19
Closed -$1.85K – 1094
2021
Q1 		$1.85K Hold
19
– – ﹤0.01% 662
2020
Q4 		$2.13K Hold
19
– – ﹤0.01% 539
2020
Q3 		$1.76K Sell
19
-1
-5% -$77 ﹤0.01% 519
2020
Q2 		$1.56K Hold
20
– – ﹤0.01% 535
2020
Q1 		$1.17K Hold
20
– – ﹤0.01% 548
2019
Q4 		$1.6K Hold
20
– – ﹤0.01% 450
2019
Q3 		$1.47K Buy
+20
New +$1.73K ﹤0.01% 464

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Raffa Wealth Management's BPMC Position: Q2 2021 in Review

Raffa Wealth Management sold out of Blueprint Medicines (BPMC) in Q2 2021, closing a stake of 19 shares — an estimated $1.85K sold.

Raffa Wealth Management first reported a position in BPMC in Q3 2019 and held it in 7 quarters. The position peaked at $2.13K in Q4 2020. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

  • Raffa Wealth Management reported no remaining Blueprint Medicines position as of Q2 2021 after selling out during the quarter.
  • Raffa Wealth Management sold 19 Blueprint Medicines shares in Q2 2021, an estimated $1.85K.
  • Raffa Wealth Management first reported a position in Blueprint Medicines in Q3 2019 and held it in 7 quarters.
  • Raffa Wealth Management's Blueprint Medicines position peaked at $2.13K in Q4 2020.
  • 281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on Raffa Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2026.